Providence St. Joseph Medical Center

Burbank, California 91505

1 studies enrolling now · 19 studies all time

What they study most

Aneurysmal Subarachnoid Hemorrhage (aSAH), Cardiac Resynchronization Therapy, Cardiovascular Disease, Cerebral Vasospasm, Chemotherapy-Induced Peripheral Neuropathy, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, Defibrillators, Implantable, Heart Disease, Heart Failure, Hodgkin Disease

Studies at this site

• Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts — Recruiting now
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer — Running, not enrolling
• A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) — Completed
• S-ICD® System Post Approval Study — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. — Stopped early
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL — Withdrawn before enrolling
• PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) — Completed
• Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer — Stopped early
• Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy — Completed